1. Home
  2. BNGO

as of 12-03-2025 4:00pm EST

$1.73
+$0.05
+2.98%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Chart Type:
Time Range:
Founded: 2003 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 24.3M IPO Year: 2018
Target Price: $6.33 AVG Volume (30 days): 303.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -11.75 EPS Growth: N/A
52 Week Low/High: $1.45 - $22.80 Next Earning Date: 11-13-2025
Revenue: $28,720,000 Revenue Growth: -13.84%
Revenue Growth (this year): -6.75% Revenue Growth (next year): 24.54%

AI-Powered BNGO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 21 hours ago

AI Recommendation

hold
Model Accuracy: 80.26%
80.26%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Bionano Genomics Inc. News

BNGO Breaking Stock News: Dive into BNGO Ticker-Specific Updates for Smart Investing

All BNGO News

Share on Social Networks: